Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics

Area of Science:

• Nanotechnology
• Medical Imaging
• Materials Science

Background:

• Gadolinium-based contrast agents face scrutiny due to toxicity concerns.
• Manganese-based MRI contrast agents are emerging as a promising alternative.
• Nanoparticle formulations offer enhanced properties for in vivo applications.

Purpose of the Study:

• To review manganese oxide nanoparticles (MnₓOᵧ NPs) for MRI and theranostic applications.
• To discuss MnₓOᵧ NPs in +2, +3, and +4 oxidation states.
• To highlight advantages over gadolinium-based nanosystems.

Main Methods:

• Review of recent literature on MnₓOᵧ NPs for MRI.
• Analysis of magnetic properties, biocompatibility, and toxicity profiles.
• Discussion of selected examples from the past decade.

Main Results:

• MnₓOᵧ NPs exhibit favorable magnetic properties and good biocompatibility.
• These nanoparticles demonstrate an improved toxicity profile compared to Gd(III)-based systems.
• Mn ions offer advantages for next-generation MRI and theranostic contrast agents.

Conclusions:

• Manganese oxide nanoparticles are a viable alternative to gadolinium contrast agents.
• Their potential for enhancing relaxivity and MRI contrast is significant.
• MnₓOᵧ NPs represent a promising direction for advanced diagnostics and theranostics.